🔎 Trials Near Me

Home › Salivary Gland Cancer › Pennsylvania

Salivary Gland Cancer clinical trials in Pennsylvania

4 studies for Salivary Gland Cancer are looking for participants at sites in Pennsylvania.

Cities in Pennsylvania

DESTINY-PANTUMOUR04

  • Research Site, Philadelphia
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

  • UPMC Altoona, Altoona
  • UPMC-Heritage Valley Health System Beaver, Beaver
  • UPMC Hillman Cancer Center at Butler Health System, Butler
  • and 26 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05408845

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Cancer Care Associates of York (site 206), York
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Dec 11, 2025 · NCT03556228

Physiologic MR Imaging of Salivary Gland Tumors

  • Hospital of the University of Pennsylvania, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT04452162

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.